The global Peripheral Vasodilator Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Calcium Channel Blockers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Peripheral Vasodilator Drugs include Pfizer, Inc., Novartis AG, GSK plc, AstraZeneca, Merck & Co., Inc., Sanofi, Bayer AG, Abbott Laboratories and Bristol-Myers Squibb Company, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Peripheral vasodilator drugs are a class of medications used to treat conditions related to the constriction of blood vessels in the peripheral tissues of the body. These drugs work by relaxing the smooth muscles in the walls of blood vessels.
This report aims to provide a comprehensive presentation of the global market for Peripheral Vasodilator Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Vasodilator Drugs. This report contains market size and forecasts of Peripheral Vasodilator Drugs in global, including the following market information:
Global Peripheral Vasodilator Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Peripheral Vasodilator Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Peripheral Vasodilator Drugs companies in 2023 (%)
We surveyed the Peripheral Vasodilator Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peripheral Vasodilator Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Peripheral Vasodilator Drugs Market Segment Percentages, by Type, 2023 (%)
Calcium Channel Blockers
Alpha-adrenergic Blockers
Potassium Channel Activators
Others
Global Peripheral Vasodilator Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Peripheral Vasodilator Drugs Market Segment Percentages, by Application, 2023 (%)
Hospital
Retail Pharmacies
Others
Global Peripheral Vasodilator Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Peripheral Vasodilator Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peripheral Vasodilator Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Peripheral Vasodilator Drugs revenues share in global market, 2023 (%)
Key companies Peripheral Vasodilator Drugs sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Peripheral Vasodilator Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Novartis AG
GSK plc
AstraZeneca
Merck & Co., Inc.
Sanofi
Bayer AG
Abbott Laboratories
Bristol-Myers Squibb Company
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd.
Viatris, Inc.
Sun Pharmaceutical Industries Ltd.
Lupin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peripheral Vasodilator Drugs, market overview.
Chapter 2: Global Peripheral Vasodilator Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Peripheral Vasodilator Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peripheral Vasodilator Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peripheral Vasodilator Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peripheral Vasodilator Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Vasodilator Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Vasodilator Drugs Overall Market Size
2.1 Global Peripheral Vasodilator Drugs Market Size: 2023 VS 2030
2.2 Global Peripheral Vasodilator Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Peripheral Vasodilator Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Peripheral Vasodilator Drugs Players in Global Market
3.2 Top Global Peripheral Vasodilator Drugs Companies Ranked by Revenue
3.3 Global Peripheral Vasodilator Drugs Revenue by Companies
3.4 Global Peripheral Vasodilator Drugs Sales by Companies
3.5 Global Peripheral Vasodilator Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Peripheral Vasodilator Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Peripheral Vasodilator Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peripheral Vasodilator Drugs Players in Global Market
3.8.1 List of Global Tier 1 Peripheral Vasodilator Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Peripheral Vasodilator Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Peripheral Vasodilator Drugs Market Size Markets, 2023 & 2030
4.1.2 Calcium Channel Blockers
4.1.3 Alpha-adrenergic Blockers
4.1.4 Potassium Channel Activators
4.1.5 Others
4.2 By Type - Global Peripheral Vasodilator Drugs Revenue & Forecasts
4.2.1 By Type - Global Peripheral Vasodilator Drugs Revenue, 2019-2024
4.2.2 By Type - Global Peripheral Vasodilator Drugs Revenue, 2025-2030
4.2.3 By Type - Global Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Peripheral Vasodilator Drugs Sales & Forecasts
4.3.1 By Type - Global Peripheral Vasodilator Drugs Sales, 2019-2024
4.3.2 By Type - Global Peripheral Vasodilator Drugs Sales, 2025-2030
4.3.3 By Type - Global Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Peripheral Vasodilator Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peripheral Vasodilator Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacies
5.1.4 Others
5.2 By Application - Global Peripheral Vasodilator Drugs Revenue & Forecasts
5.2.1 By Application - Global Peripheral Vasodilator Drugs Revenue, 2019-2024
5.2.2 By Application - Global Peripheral Vasodilator Drugs Revenue, 2025-2030
5.2.3 By Application - Global Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Peripheral Vasodilator Drugs Sales & Forecasts
5.3.1 By Application - Global Peripheral Vasodilator Drugs Sales, 2019-2024
5.3.2 By Application - Global Peripheral Vasodilator Drugs Sales, 2025-2030
5.3.3 By Application - Global Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Peripheral Vasodilator Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Peripheral Vasodilator Drugs Market Size, 2023 & 2030
6.2 By Region - Global Peripheral Vasodilator Drugs Revenue & Forecasts
6.2.1 By Region - Global Peripheral Vasodilator Drugs Revenue, 2019-2024
6.2.2 By Region - Global Peripheral Vasodilator Drugs Revenue, 2025-2030
6.2.3 By Region - Global Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Peripheral Vasodilator Drugs Sales & Forecasts
6.3.1 By Region - Global Peripheral Vasodilator Drugs Sales, 2019-2024
6.3.2 By Region - Global Peripheral Vasodilator Drugs Sales, 2025-2030
6.3.3 By Region - Global Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Peripheral Vasodilator Drugs Revenue, 2019-2030
6.4.2 By Country - North America Peripheral Vasodilator Drugs Sales, 2019-2030
6.4.3 US Peripheral Vasodilator Drugs Market Size, 2019-2030
6.4.4 Canada Peripheral Vasodilator Drugs Market Size, 2019-2030
6.4.5 Mexico Peripheral Vasodilator Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Peripheral Vasodilator Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Peripheral Vasodilator Drugs Sales, 2019-2030
6.5.3 Germany Peripheral Vasodilator Drugs Market Size, 2019-2030
6.5.4 France Peripheral Vasodilator Drugs Market Size, 2019-2030
6.5.5 U.K. Peripheral Vasodilator Drugs Market Size, 2019-2030
6.5.6 Italy Peripheral Vasodilator Drugs Market Size, 2019-2030
6.5.7 Russia Peripheral Vasodilator Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Peripheral Vasodilator Drugs Market Size, 2019-2030
6.5.9 Benelux Peripheral Vasodilator Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Peripheral Vasodilator Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Peripheral Vasodilator Drugs Sales, 2019-2030
6.6.3 China Peripheral Vasodilator Drugs Market Size, 2019-2030
6.6.4 Japan Peripheral Vasodilator Drugs Market Size, 2019-2030
6.6.5 South Korea Peripheral Vasodilator Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Peripheral Vasodilator Drugs Market Size, 2019-2030
6.6.7 India Peripheral Vasodilator Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Peripheral Vasodilator Drugs Revenue, 2019-2030
6.7.2 By Country - South America Peripheral Vasodilator Drugs Sales, 2019-2030
6.7.3 Brazil Peripheral Vasodilator Drugs Market Size, 2019-2030
6.7.4 Argentina Peripheral Vasodilator Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peripheral Vasodilator Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Peripheral Vasodilator Drugs Sales, 2019-2030
6.8.3 Turkey Peripheral Vasodilator Drugs Market Size, 2019-2030
6.8.4 Israel Peripheral Vasodilator Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Peripheral Vasodilator Drugs Market Size, 2019-2030
6.8.6 UAE Peripheral Vasodilator Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Company Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Peripheral Vasodilator Drugs Major Product Offerings
7.1.4 Pfizer, Inc. Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer, Inc. Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Peripheral Vasodilator Drugs Major Product Offerings
7.2.4 Novartis AG Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Novartis AG Key News & Latest Developments
7.3 GSK plc
7.3.1 GSK plc Company Summary
7.3.2 GSK plc Business Overview
7.3.3 GSK plc Peripheral Vasodilator Drugs Major Product Offerings
7.3.4 GSK plc Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.3.5 GSK plc Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Peripheral Vasodilator Drugs Major Product Offerings
7.4.4 AstraZeneca Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc. Company Summary
7.5.2 Merck & Co., Inc. Business Overview
7.5.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Major Product Offerings
7.5.4 Merck & Co., Inc. Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Merck & Co., Inc. Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Peripheral Vasodilator Drugs Major Product Offerings
7.6.4 Sanofi Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Sanofi Key News & Latest Developments
7.7 Bayer AG
7.7.1 Bayer AG Company Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Peripheral Vasodilator Drugs Major Product Offerings
7.7.4 Bayer AG Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Bayer AG Key News & Latest Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Peripheral Vasodilator Drugs Major Product Offerings
7.8.4 Abbott Laboratories Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Abbott Laboratories Key News & Latest Developments
7.9 Bristol-Myers Squibb Company
7.9.1 Bristol-Myers Squibb Company Company Summary
7.9.2 Bristol-Myers Squibb Company Business Overview
7.9.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.10 Boehringer Ingelheim International GmbH
7.10.1 Boehringer Ingelheim International GmbH Company Summary
7.10.2 Boehringer Ingelheim International GmbH Business Overview
7.10.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Major Product Offerings
7.10.4 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.11.2 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Business Overview
7.11.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Major Product Offerings
7.11.4 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.12 Viatris, Inc.
7.12.1 Viatris, Inc. Company Summary
7.12.2 Viatris, Inc. Peripheral Vasodilator Drugs Business Overview
7.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Major Product Offerings
7.12.4 Viatris, Inc. Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Viatris, Inc. Key News & Latest Developments
7.13 Sun Pharmaceutical Industries Ltd.
7.13.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.13.2 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Business Overview
7.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Major Product Offerings
7.13.4 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.13.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.14 Lupin
7.14.1 Lupin Company Summary
7.14.2 Lupin Business Overview
7.14.3 Lupin Peripheral Vasodilator Drugs Major Product Offerings
7.14.4 Lupin Peripheral Vasodilator Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Lupin Key News & Latest Developments
8 Global Peripheral Vasodilator Drugs Production Capacity, Analysis
8.1 Global Peripheral Vasodilator Drugs Production Capacity, 2019-2030
8.2 Peripheral Vasodilator Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Peripheral Vasodilator Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peripheral Vasodilator Drugs Supply Chain Analysis
10.1 Peripheral Vasodilator Drugs Industry Value Chain
10.2 Peripheral Vasodilator Drugs Upstream Market
10.3 Peripheral Vasodilator Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peripheral Vasodilator Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Peripheral Vasodilator Drugs in Global Market
Table 2. Top Peripheral Vasodilator Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Peripheral Vasodilator Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Peripheral Vasodilator Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Peripheral Vasodilator Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Peripheral Vasodilator Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Peripheral Vasodilator Drugs Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Peripheral Vasodilator Drugs Product Type
Table 9. List of Global Tier 1 Peripheral Vasodilator Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peripheral Vasodilator Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Peripheral Vasodilator Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Peripheral Vasodilator Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Peripheral Vasodilator Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Peripheral Vasodilator Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Peripheral Vasodilator Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Peripheral Vasodilator Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Peripheral Vasodilator Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Peripheral Vasodilator Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Peripheral Vasodilator Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Peripheral Vasodilator Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Peripheral Vasodilator Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Peripheral Vasodilator Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Peripheral Vasodilator Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Peripheral Vasodilator Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Peripheral Vasodilator Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Peripheral Vasodilator Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Peripheral Vasodilator Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Peripheral Vasodilator Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Peripheral Vasodilator Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Peripheral Vasodilator Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Peripheral Vasodilator Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Peripheral Vasodilator Drugs Sales, (K Units), 2025-2030
Table 46. Pfizer, Inc. Company Summary
Table 47. Pfizer, Inc. Peripheral Vasodilator Drugs Product Offerings
Table 48. Pfizer, Inc. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Pfizer, Inc. Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Peripheral Vasodilator Drugs Product Offerings
Table 52. Novartis AG Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Novartis AG Key News & Latest Developments
Table 54. GSK plc Company Summary
Table 55. GSK plc Peripheral Vasodilator Drugs Product Offerings
Table 56. GSK plc Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. GSK plc Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Peripheral Vasodilator Drugs Product Offerings
Table 60. AstraZeneca Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Merck & Co., Inc. Company Summary
Table 63. Merck & Co., Inc. Peripheral Vasodilator Drugs Product Offerings
Table 64. Merck & Co., Inc. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Merck & Co., Inc. Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Peripheral Vasodilator Drugs Product Offerings
Table 68. Sanofi Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Sanofi Key News & Latest Developments
Table 70. Bayer AG Company Summary
Table 71. Bayer AG Peripheral Vasodilator Drugs Product Offerings
Table 72. Bayer AG Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Bayer AG Key News & Latest Developments
Table 74. Abbott Laboratories Company Summary
Table 75. Abbott Laboratories Peripheral Vasodilator Drugs Product Offerings
Table 76. Abbott Laboratories Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Abbott Laboratories Key News & Latest Developments
Table 78. Bristol-Myers Squibb Company Company Summary
Table 79. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product Offerings
Table 80. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Bristol-Myers Squibb Company Key News & Latest Developments
Table 82. Boehringer Ingelheim International GmbH Company Summary
Table 83. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product Offerings
Table 84. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Boehringer Ingelheim International GmbH Key News & Latest Developments
Table 86. Teva Pharmaceutical Industries Ltd. Company Summary
Table 87. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Offerings
Table 88. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 90. Viatris, Inc. Company Summary
Table 91. Viatris, Inc. Peripheral Vasodilator Drugs Product Offerings
Table 92. Viatris, Inc. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Viatris, Inc. Key News & Latest Developments
Table 94. Sun Pharmaceutical Industries Ltd. Company Summary
Table 95. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Offerings
Table 96. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 98. Lupin Company Summary
Table 99. Lupin Peripheral Vasodilator Drugs Product Offerings
Table 100. Lupin Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Lupin Key News & Latest Developments
Table 102. Peripheral Vasodilator Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 103. Global Peripheral Vasodilator Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 104. Global Peripheral Vasodilator Drugs Production by Region, 2019-2024 (K Units)
Table 105. Global Peripheral Vasodilator Drugs Production by Region, 2025-2030 (K Units)
Table 106. Peripheral Vasodilator Drugs Market Opportunities & Trends in Global Market
Table 107. Peripheral Vasodilator Drugs Market Drivers in Global Market
Table 108. Peripheral Vasodilator Drugs Market Restraints in Global Market
Table 109. Peripheral Vasodilator Drugs Raw Materials
Table 110. Peripheral Vasodilator Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Peripheral Vasodilator Drugs Downstream
Table 112. Peripheral Vasodilator Drugs Downstream Clients in Global Market
Table 113. Peripheral Vasodilator Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Peripheral Vasodilator Drugs Segment by Type in 2023
Figure 2. Peripheral Vasodilator Drugs Segment by Application in 2023
Figure 3. Global Peripheral Vasodilator Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Peripheral Vasodilator Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Peripheral Vasodilator Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Peripheral Vasodilator Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Peripheral Vasodilator Drugs Revenue in 2023
Figure 9. By Type - Global Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Peripheral Vasodilator Drugs Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Peripheral Vasodilator Drugs Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Peripheral Vasodilator Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
Figure 23. US Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
Figure 28. Germany Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
Figure 37. China Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Peripheral Vasodilator Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Peripheral Vasodilator Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Peripheral Vasodilator Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Peripheral Vasodilator Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Peripheral Vasodilator Drugs by Region, 2023 VS 2030
Figure 54. Peripheral Vasodilator Drugs Industry Value Chain
Figure 55. Marketing Channels
